$PKE

PARK AEROSPACE CORP (PKE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

PARK AEROSPACE CORP (PKE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. pke20260709_8k.htm false 0000076267 0000076267 2026-07-07 2026-07-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event repor

Original reporting
Published Jul 9, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PKE
Neutral
medium confidence
Mentioned
$PKE
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PKENeutralLow
01

Why it matters

This is a governance and leadership update. Without accompanying operational or financial disclosures, it is more likely to affect sentiment and internal execution expectations than to drive a fundamental repricing by itself.

02

Market read

Traders may treat this as a low-signal catalyst unless subsequent filings connect the change to specific programs, restructuring, or guidance.

03

What to watch

Compensation increase (base salary $193,000 to $205,000 effective July 13, 2026) may be interpreted as a mandate for near-term operational delivery, even without explicit metrics.

Relevance 6/10Novelty 4/10Timing: Filed July 9, 2026, covering an immediate-effect executive change dated July 7, 2026.

Background

The company reported Item 5.02 on Form 8-K, documenting an officer transition and related compensatory arrangement.

Company-level read

Ticker impact

$PKENeutralMedium confidence
Context

Park Aerospace filed an 8-K that terminated SVP/GM Cory Nickel and appointed John Jamieson as SVP and General Manager effective immediately.

Expected impact

Limited immediate price impact expected; any reaction would likely be modest unless investors view the change as signaling operational stress or a turnaround.

Evidence & confidence

The filing discloses an executive departure and replacement plus compensation adjustment, but provides no financial guidance, restructuring details, or quantified operational outcomes.

Market effects

No direct sector read-across; aerospace/defense execution risk may be monitored, but the filing lacks program or contract specifics.

None indicated.

None indicated.

Counterpoint

The lack of stated reasons could mean the change is precautionary or performance-driven; traders may still watch for follow-on disclosures (program wins, cost actions, or further officer changes).

Key entities

  • Park Aerospace Corp.

    US-listed aerospace company filing the 8-K for an executive departure and appointment.

  • Cory Nickel

    Senior Vice President and General Manager whose employment was terminated effective immediately on July 7, 2026.

  • John Jamieson

    Appointed Senior Vice President and General Manager effective immediately; previously SVP Project Management since July 30, 2024.

Related articles

$PKEMed

Park Aerospace Q1 Earnings Call Highlights

Park Aerospace (NYSE:PKE) Q1 call said Q2 FY2027 sales are forecast at $19.5 million to $21.0 million and adjusted EBITDA at $4.3 million to $5.1 million. GE Aerospace engine-program sales were $7.1 million in Q1, $7.5 million to $8.25 million in Q2, and $34 million to $38 million for FY. Park also outlined $65 million Tulsa plant and $25 million ArianeGroup C2B fabric plant advance payments, plus a $50 million ATM offering and $0.125 dividend.

$PKEMed

PARK AEROSPACE CORP (PKE): Results of Operations and Financial Condition

PARK AEROSPACE CORP (PKE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_990131.htm EXHIBIT 99.1 ex_990131.htm Exhibit 99.1 NEWS RELEASE Contact: Donna D’Amico-Annitto 486 North Oliver Road, Bldg. Z Newton, Kansas 67114 (316) 283-6500 PARK AEROSPACE CORP. REPORTS FIRST QUARTER RESULTS Newton, Kansas, Monday, July 20, 2026…..Park Aerospace

$PKEMedAI 9/10

Park Aerospace Q4 Earnings Call Highlights

Park Aerospace’s Q4 call covered C2B fabric supply, missed shipments, and growth programs. The company sold $1.3M of ablative materials made with C2B fabric and said margins are “significant.” It cited $715,000 missed shipments in Q4 and expects ~$1.3M in Q1. GE Aerospace program sales were $8.1M Q4 and $29.3M FY2026; Q1 forecast $6.8M–$7.4M. Park also discussed missile ablative demand, capacity expansion, and an ATM raising $22.8M.

$PKELow

Park Aerospace Q4 2026 Earnings Call Transcript - Park Aerospace (NYSE:PKE)

Park Aerospace (NYSE:PKE) discussed customer mix and aerospace segment trends in its Q4 2026 earnings call transcript. Management said military demand appears to be increasing versus prior years, while commercial normalized post-pandemic. The company highlighted niche military programs and missile systems, and reviewed its GE Aerospace-linked jet engine work tied to Middle River Aerostructure Systems. It also cited Airbus A320neo delivery/backlog figures and CFM Leap OneA market share from AeroE

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.